|Day Low/High||38.09 / 38.68|
|52 Wk Low/High||27.88 / 40.97|
Take upbeat outlooks for equities with a grain of salt, and try these sectors to stay safe.
Pfizer pushes higher on price increases.
A retest of the October lows seems almost too obvious but it is hard to dispute the possibility that it may occur.
Pharma could be the best parking spot for your money if the market keeps trending downward.
Shares of the New York City-based pharmaceutical giant are rising on Monday.
Pfizer trades with a trailing PE of 15 and is expected to grow earnings 2% in 2019.
The cancer drug market is expected to grow from a surveyed total value of $78 billion in 2015 to over $110 billion by 2020.
Let's check our indicators.
Eli Lilly's self-policing on drug pricing protects it from the most prominent political pushbacks.
And keep in mind that earnings season is not over, and there's enough juice left to impact the marketplace.
Once the safest stocks in the book, the big-cap drug companies are now toxic.
Some groups that have been in horrendous bear market mode finally caught a bid.
My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.
It becomes difficult for me to tell you where to run in these markets...
Tesla produced 80,000 vehicles in the quarter, according to electrek.
We are about a 20 minutes from the open of a new trading week. Futures are up on news of a trade agreement between Canada and the United States that will lessen overall trade tensions and allow the country to focus on China. Tesla up strongly in pre...
Straying from these names could land you in quicksand as the 4th quarter begins.
Markets were higher Tuesday after starting Tuesday's session off in the green.
The industry has taken to smaller, voluntary measures to avoid serious federal action on pricing.
Traders should raise sell stops to just above $40 from below $35.50
There's too much evidence of economic strength, so don't interpret these moves as a sign of a real slowdown.
Take a pass on stocks like Kimberly-Clark or Pfizer that are bucking Wednesday's sell-off and going higher.
Tech is still the equity market's leading sector over three months -- and over most timeframes going back years.